|
|
Volumn 137, Issue 2, 2009, Pages 734-735
|
|
Targeting Farnesoid X Receptor in Hepatic and Biliary Inflammatory Diseases
a a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
3 [2 [2 CHLORO 4 [3 (2,6 DICHLOROPHENYL) 5 ISOPROPYL 4 ISOXAZOLYLMETHOXY]PHENYL]VINYL]BENZOIC ACID;
6 ETHYL CHENODEOXYCHOLIC ACID;
CELL NUCLEUS RECEPTOR;
CHENODEOXYCHOLIC ACID;
FARNESOID X RECEPTOR;
IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;
LIPOPOLYSACCHARIDE;
UNCLASSIFIED DRUG;
ARTICLE;
BILE ACID METABOLISM;
BILIARY TRACT DISEASE;
CHRONIC LIVER DISEASE;
HEPATITIS;
HUMAN;
LIVER CELL;
NONHUMAN;
PATHOPHYSIOLOGY;
PRIMARY BILIARY CIRRHOSIS;
PRIMARY SCLEROSING CHOLANGITIS;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
TRANSCRIPTION REGULATION;
|
|
EID: 67650935683
PISSN: 00165085
EISSN: None
Source Type: Journal
DOI: 10.1053/j.gastro.2009.06.027 Document Type: Note |
|
Times cited : (12)
|
|
References (0)
|